Enveric Biosciences, Inc.
ENVB· Nasdaq
Filed Aug 2, 2011 · 10-Q · 33 days after period end · 0001477932-11-001265
| Metric | Q2 2011 | Q2 2010 |
|---|---|---|
| Net Income | -$3.63K | $0.00 |
| EPS Diluted | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Enveric Biosciences, Inc. · CIK 890821 · Engraved from SEC EDGAR
ended Jun 30, 2011 · filed Aug 2, 2011 · 33 d after period end